Chiron Real Estate (XRN) closed out FY 2025 with Q4 total revenue of US$38.4 million and basic EPS of a US$0.55 loss, while over the last 12 months revenue came in at US$148.2 million with EPS of a US$0.91 loss and revenue growth of 2.6% per year. Over recent periods, the company has seen quarterly revenue move from US$35.1 million in Q4 2024 to US$38.4 million in Q4 2025, while basic EPS shifted from US$0.10 to a loss of US$0.55. This sets up a mixed picture, where modest top line progress sits alongside pressured margins and softer earnings power.
See our full analysis for Chiron Real Estate.With the headline numbers on the table, the next step is to see how these results match up against the widely held narratives around Chiron Real Estate's growth potential, risk profile, and long term earnings power.
See what the community is saying about Chiron Real Estate
FFO Holds Up Better Than EPS Losses
- For FY 2025, quarterly Funds From Operations sat in a fairly tight range of about US$14.3 million to US$14.8 million in Q1 to Q3, even as basic EPS moved from a profit of US$0.16 in Q1 to a loss of US$0.55 in Q4 and trailing 12 month EPS landed at a loss of US$0.91.
- What stands out for the bullish view is that REIT specific cash flow metrics look steadier than net income. Bullish investors argue this can support the thesis that earnings power is stronger than GAAP losses suggest.
- Quarterly FFO between US$11.0 million and US$14.8 million from Q3 2024 to Q3 2025 sits alongside TTM net income of a US$12.1 million loss, so bulls point to a gap between accounting losses and cash generation.
- Bulls also highlight that TTM FFO per share between about US$3.7 and US$3.9 across the last six quarters provides a cash flow base they believe could support future rent and earnings growth, even though the company is currently unprofitable on a TTM net income basis.
Investors who want to see how that stronger cash flow argument is built out over time can go straight to the 🐂 Chiron Real Estate Bull Case
Debt Costs And Dividend Coverage Under Pressure
- On a trailing 12 month basis, the company reported a net loss of US$12.1 million, and the analysis flags that both interest payments and an 8.2% dividend yield are not well covered by earnings, with losses having grown roughly 9.2% per year over the past five years.
- Bears focus on these coverage gaps, arguing that higher refinancing costs and weak interest coverage could weigh on future cash available for dividends and reinvestment.
- Critics point to the combination of TTM losses and flagged weak interest coverage as evidence that higher debt costs can directly squeeze funds from operations and limit flexibility, even when revenue over the last 12 months sits at US$148.2 million.
- The same data set that shows modest 2.6% revenue growth per year also highlights that the current 8.2% yield is not supported by recent earnings, which bears see as reinforcing concerns about how sustainable current payout levels are if losses continue.
If you are weighing those balance sheet and payout risks, it is worth seeing how cautious investors frame them in the 🐻 Chiron Real Estate Bear Case
Slow 2.6% Growth Versus Market And Valuation Gap
- Over the last 12 months, revenue growth of 2.6% per year trails the 10.4% benchmark for the US market, yet the shares at US$36.60 trade on a P/S of 3.3x compared with 3.5x for peers and 4.9x for the North American Health Care REITs industry, and the price is also below the indicated DCF fair value of about US$62.41.
- Consensus style commentary often highlights this mix of slower growth but lower valuation multiples, which creates a clear tension for investors to think through.
- On one hand, trailing net losses and slower 2.6% revenue growth keep the business behind the broader US market growth rate, which some investors see as a drag on sentiment.
- On the other hand, trading about 41% below the DCF fair value and at a P/S below both peers and the wider industry means some investors view the current US$36.60 price as already reflecting many of the earnings and coverage concerns highlighted in the recent data.
Next Steps
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for Chiron Real Estate on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.
If this mix of cautious and optimistic signals leaves you unsure, take a closer look at the numbers yourself and form your own view with 2 key rewards and 3 important warning signs
See What Else Is Out There
Chiron Real Estate is wrestling with losses, weak dividend and interest coverage, and slow 2.6% revenue growth compared with the broader US market.
If those pressure points on earnings and payouts concern you, this is a good moment to check our solid balance sheet and fundamentals stocks screener (41 results) and look for businesses with sturdier financial foundations.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com